Pharmacists Fight Back in Medicare and Medicaid Act
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 42
- Latest action
- Dec 11, 2025
What it does
The bill amends Medicare and Medicaid provisions to impose new requirements on pharmacy benefit managers (PBMs) and plan sponsors, including standardized pharmacy reimbursement based on national average drug acquisition cost plus a capped dispensing fee, mandatory pass-through of manufacturer rebates to reduce patient cost-sharing at the point of sale, annual reporting on compliance, and a prohibition on steering patients to specific pharmacies. These requirements apply to Medicare Part D prescription drug plans and Medicaid contracts beginning in 2027, affecting PBMs, plan sponsors, pharmacies, and enrolled individuals by aiming to increase transparency and reduce costs tied to PBM…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.